Long-term β-blocker therapy decreases blood lactate concentration in severely septic patients

Critical Care Medicine

Volumn 43, Issue 12, 2015, Pages 2616-2622

  Contenti, Julie ^a,b   Occelli, Céline ^a   Corraze, Hervé ^a   Lemoël, Fabien ^a   Levraut, Jacques ^a,b  

^a PASTEUR HOSPITAL   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

glycolysis; lactate; sepsis; shock; triage; blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYPERTENSIVE FACTOR; LACTIC ACID; BIOLOGICAL MARKER;

AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BETA ADRENERGIC STIMULATION; CHRONIC KIDNEY FAILURE; CHRONIC LIVER FAILURE; CHRONIC RESPIRATORY FAILURE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE ASSESSMENT; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; GLYCOLYSIS; HUMAN; INFECTION; INTENSIVE CARE; LACTATE BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PREDISPOSITION INSULT RESPONSE OF ORGAN FAILURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL; BLOOD; MIDDLE AGED; MULTIPLE ORGAN FAILURE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; BIOMARKERS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITAL MORTALITY; HUMANS; LACTIC ACID; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RETROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC;

EID: 84947492248     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001308     Document Type: Article

References (27)

1. Dellinger RP, Levy MM, Rhodes A, Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013 41 580 637
2. Casserly B, Phillips GS, Schorr C, Lactate measurements in sepsis-induced tissue hypoperfusion: Results from the Surviving Sepsis Campaign database. Crit Care Med 2015 43 567 573
3. Jansen TC, van Bommel J, Bakker J, Blood lactate monitoring in critically ill patients: A systematic health technology assessment. Crit Care Med 2009 37 2827 2839
4. Contenti J, Corraze H, Lemoël F, Effectiveness of arterial, venous, and capillary blood lactate as a sepsis triage tool in ED patients. Am J Emerg Med 2015 33 167 172
5. Jansen TC, van Bommel J, Schoonderbeek FJ, LACTATE Study Group Early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010 182 752 761
6. Jones AE, Shapiro NI, Trzeciak S, Emergency Medicine Shock Research Network (EMShockNet) Investigators Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial. JAMA 2010 303 739 746
7. James JH, Luchette FA, McCarter FD, Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999 354 505 508
8. Garcia-Alvarez M, Marik P, Bellomo R, Sepsis-Associated hyperlactatemia. Crit Care 2014 18 503
9. Tuchschmidt J, Oblitas D, Fried JC, Oxygen consumption in sepsis and septic shock. Crit Care Med 1991 19 664 671
10. Rivers E, Nguyen B, Havstad S, Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 345 1368 1377
11. Levraut J, Ciebiera JP, Chave S, Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 1998 157 1021 1026
12. Levraut J, Ichai C, Petit I, Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients. Crit Care Med 2003 31 705 710
13. Levy B, Desebbe O, Montemont C, Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock 2008 30 417 421
14. Glitsch HG, Tappe A, The Na+/K+ pump of cardiac Purkinje cells is preferentially fuelled by glycolytic ATP production. Pflugers Arch 1993 422 380 385
15. Lewis L, Ferguson I, House SL, Albuterol administration is commonly associated with increases in serum lactate in patients with asthma treated for acute exacerbation of asthma. Chest 2014 145 53 59
16. Levy B, Gibot S, Franck P, Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: A prospective study. Lancet 2005 365 871 875
17. Howell MD, Talmor D, Schuetz P, Proof of principle: The predisposition, infection, response, organ failure sepsis staging system. Crit Care Med 2011 39 322 327
18. Yealy DM, Kellum JA, Huang DT, A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014 370 1683 93
19. Mouncey PR, Osborn TM, Power GS, ProMISe Trial Investigators Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015 372 1301 1311
20. Peake SL, Delaney A, Bailey M, Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014 371 1496 506
21. Kaukonen KM, Bailey M, Pilcher D, Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med 2015 372 1629 1638
22. McCarter FD, James JH, Luchette FA, Adrenergic blockade reduces skeletal muscle glycolysis and Na(+), K(+)-ATPase activity during hemorrhage. J Surg Res 2001 99 235 244
23. Mégarbane B, Deye N, Malissin I, Usefulness of the serum lactate concentration for predicting mortality in acute beta-blocker poisoning. Clin Toxicol (Phila) 2010 48 974 978
24. Macchia A, Romero M, Comignani PD, Previous prescription of β-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis. Crit Care Med 2012 40 2768 2772
25. Morelli A, Ertmer C, Westphal M, Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: A randomized clinical trial. JAMA 2013 310 1683 1691
26. Ackland GL, Yao ST, Rudiger A, Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-Adrenoceptor blockade in severe sepsis in rats. Crit Care Med 2010 38 388 394
27. Schmitz D, Wilsenack K, Lendemanns S, Beta-Adrenergic blockade during systemic inflammation: Impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation 2007 72 286 294